Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine Neau-Cransac

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|December 2, 2008
Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathyMartine Neau-Cransac, Karine Moreau, Colette Deminière, et al.
Viral Immunology|April 2, 2005
Modifications of T-lymphocyte subsets before and during interferon and ribavirin treatment for chronic hepatitis C infectionMartine Neau-Cransac, Juliette Foucher, Victor De Ledinghen, et al.
Dermatology (Basel, Switzerland)|November 16, 2005
Uncommon localization of calcinosis cutis after liver transplantationMartine Neau-Cransac, Sébastien Lepreux, Christine Labreze, et al.
Clinical Transplantation|September 13, 2002
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawalMartine Neau-Cransac, Delphine Morel, Pierre-Henri Bernard, et al.
Clinical Transplantation|July 22, 2014
Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitorsEmma Perbos, Estelle Juinier, Gwendaline Guidicelli, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 7, 2018
De Novo Primary Liver Cancer After Liver Transplantation: A French National Study on 15803 PatientsManon Allaire, Olivier Sérée, Audrey Coilly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2015
Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendationsAudrey Coilly, Yvon Calmus, Faiza Chermak, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2011
Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysisFaouzi Saliba, Sébastien Dharancy, Richard Lorho, et al.
Transplant Immunology|September 1, 2015
Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantationsMartine Neau-Cransac, Brigitte Le Bail, Gwendaline Guidicelli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 17, 2006
Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipientsIsabelle Garrigue, Sébastien Boucher, Lionel Couzi, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|December 2, 2008
Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathyMartine Neau-Cransac, Karine Moreau, Colette Deminière, et al.
Viral Immunology|April 2, 2005
Modifications of T-lymphocyte subsets before and during interferon and ribavirin treatment for chronic hepatitis C infectionMartine Neau-Cransac, Juliette Foucher, Victor De Ledinghen, et al.
Dermatology (Basel, Switzerland)|November 16, 2005
Uncommon localization of calcinosis cutis after liver transplantationMartine Neau-Cransac, Sébastien Lepreux, Christine Labreze, et al.
Clinical Transplantation|September 13, 2002
Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawalMartine Neau-Cransac, Delphine Morel, Pierre-Henri Bernard, et al.
Clinical Transplantation|July 22, 2014
Evolution of donor-specific antibodies (DSA) and incidence of de novo DSA in solid organ transplant recipients after switch to everolimus alone or associated with low dose of calcineurin inhibitorsEmma Perbos, Estelle Juinier, Gwendaline Guidicelli, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 7, 2018
De Novo Primary Liver Cancer After Liver Transplantation: A French National Study on 15803 PatientsManon Allaire, Olivier Sérée, Audrey Coilly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 13, 2015
Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendationsAudrey Coilly, Yvon Calmus, Faiza Chermak, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 9, 2011
Conversion to everolimus in maintenance liver transplant patients: a multicenter, retrospective analysisFaouzi Saliba, Sébastien Dharancy, Richard Lorho, et al.
Transplant Immunology|September 1, 2015
Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantationsMartine Neau-Cransac, Brigitte Le Bail, Gwendaline Guidicelli, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 17, 2006
Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipientsIsabelle Garrigue, Sébastien Boucher, Lionel Couzi, et al.
Pageof 4